Immunopeptidome analysis reveals SERPINB3 as an autoantigen driving eczematized psoriasis

免疫肽组分析揭示SERPINB3是驱动湿疹样银屑病发生的自身抗原

阅读:2
作者:Manja Jargosch,Jomy Kuruvila,Emanuele Scala,Johannes Grosch,Jessica Eigemann ,Sophia Wasserer,Shalva Lekiashvili,Nico Trautwein,Daniel Johannes Kowalewski,Alexander Böhner,Yigit Köseoglu,Christina Hillig,Jenny Thomas ,Felix Lauffer ,Carsten B Schmidt-Weber,Michael P Menden,Juliane S Walz ,Susanne Kaesler,Stefanie Eyerich,Simon Blank,Hans-Georg Rammensee ,Tilo Biedermann,Kilian Eyerich,Zsuzsanna Kurgyis,Lena K Freudenmann ,Natalie Garzorz-Stark

Abstract

Psoriasis (Pso) is a chronic inflammatory skin disease driven by T helper 17 (TH17) cells, with several clinical subtypes. While self-reactive immune responses have been observed, the role of autoantigens in Pso remains unclear. Using immunopeptidomics, we identified serpin family B member 3 (SERPINB3) and SERPINB4 as candidate autoantigens in Pso skin. In a mouse model, the SERPINB3 ortholog Serpinb3b enhanced inflammation, promoted tissue-resident memory T cells, and skewed immunity toward a TH2 phenotype. In humans, SERPINB3 reactivity was specifically associated with "eczematized psoriasis" (EczPso), a subtype marked by TH2/TH17 immune signatures. SERPINB3 protein was enriched in EczPso lesions and highly secreted by keratinocytes under combined TH2/TH17 stimulation. Lesional T cells from EczPso-but not from eczema or classical plaque Pso-proliferated in response to SERPINB3 and induced EczPso-like features in a skin model. Our findings identify SERPINB3 as an autoantigen driving a distinct Pso subtype, supporting more precise diagnosis and therapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。